Yubo Biotech EBITDA 2010-2024 | YBGJ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Yubo Biotech ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Yubo Biotech ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$209.2B
Intuitive Surgical (ISRG)	$190.8B
Alcon (ALC)	$45.5B
IQVIA Holdings (IQV)	$39.4B
Edwards Lifesciences (EW)	$39.3B
IDEXX Laboratories (IDXX)	$35.8B
DexCom (DXCM)	$27.5B
Waters (WAT)	$22.6B
SONOVA HOLDING (SONVY)	$22.1B
STERIS (STE)	$21.9B
Hologic (HOLX)	$18.4B
Sysmex ADR (SSMXY)	$12.9B
Fresenius Medical Care AG KGaA (FMS)	$12.6B
Globus Medical (GMED)	$11.1B
Penumbra (PEN)	$9.3B
Teleflex (TFX)	$9.2B
Masimo (MASI)	$8.7B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$5.1B
Integer Holdings (ITGR)	$4.7B
Inari Medical (NARI)	$3.1B
Veracyte (VCYT)	$3B
TransMedics (TMDX)	$3B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.4B